Diazoxide
NDC 13517-100, diazoxide, suspension, from e5 Pharma, LLC.
- Product NDC
- 13517-100
- Status
- Listed
- Labeler
- e5 Pharma, LLC
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211050
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/13517-100 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DIAZOXIDE50 mg/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 13517-100-30 | 13517010030 | 1 BOTTLE, DROPPER in 1 CARTON (13517-100-30) / 30 mL in 1 BOTTLE, DROPPER |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c0237320-2d3f-4907-a4d3-08f138aa4ca8NADAC price for package 13517010030
GET /v1/drugs/nadac/13517010030
Use it
Look up 13517-100 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/13517-100 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 13517-100. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.